{
    "clinical_study": {
        "@rank": "6630", 
        "arm_group": {
            "arm_group_label": "Abnormal lymph nodes", 
            "arm_group_type": "Other", 
            "description": "There is only one arm to this study and includes all eligible and consented patients with abnormal axillary lymph node on ultrasound."
        }, 
        "brief_summary": {
            "textblock": "To compare accuracy of ultrasound guided fine needle aspiration (FNA) to core needle biopsy\n      (CNB) of ultrasound detected abnormal axillary lymph nodes in patients with newly diagnosed\n      invasive breast cancer or suspected invasive breast cancer.\n\n      Hypothesis: FNA and CNB have equivalent diagnostic accuracies\n\n      In order to prove our hypothesis, we will perform FNA and CNB on the same lymph node in each\n      consented patient. The two samples will be evaluated separately by different pathologists\n      blinded to the material in the other sample.\n\n      The results of the biopsies will be compared to the gold standard (lymph node excision)."
        }, 
        "brief_title": "Accuracy of FNA Versus CNB of Abnormal Axillary Lymph Nodes in Setting of Invasive Breast Cancer", 
        "condition": "Breast Cancer", 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Recent or suspected diagnosis of invasive breast cancer with abnormal ipsilateral\n             axillary lymph node\n\n          -  Able to provide informed consent\n\n        Exclusion Criteria:\n\n          -  Lymph node not amenable to core biopsy\n\n          -  Patient is unlikely to undergo lymph node excision (i.e. elderly patient with\n             co-morbidities)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02019303", 
            "org_study_id": "00068472"
        }, 
        "intervention": {
            "arm_group_label": "Abnormal lymph nodes", 
            "description": "Both procedures will be performed on the same lymph node", 
            "intervention_name": "FNA and Core biopsy", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 17, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Salt Lake City", 
                    "country": "United States", 
                    "state": "Utah", 
                    "zip": "84132"
                }, 
                "name": "Huntsman Cancer Hospital"
            }, 
            "investigator": {
                "last_name": "Nicole Winkler, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Ultrasound Guided Core Needle Biopsy Versus Fine Needle Aspiration of Morphologically Abnormal Axillary Lymph Node in Patients With New Diagnosis or Suspected Diagnosis of Invasive Breast Carcinoma", 
        "overall_contact": {
            "email": "nicole.winkler@hsc.utah.edu", 
            "last_name": "Nicole Winkler, MD", 
            "phone": "801-587-4309"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Accuracy will be determined by comparing the results of the FNA and CNB performed on the same lymph node to the gold standard using a paired test of equivalence. The gold standard is the final pathologic diagnosis of excised lymph node containing biopsy marker (either sentinel lymph node biopsy or axillary dissection). Surgical excision of pre-operatively sampled lymph node marks the end of study participation for each patient.", 
            "measure": "Accuracy of FNA and CNB", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02019303"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Pain associated with each biopsy method will be assessed with a visual analog scale (0- 10) after a baseline pain measurement. The results will be compared to baseline pain level and analyzed using a paired t test.", 
            "measure": "Pain associated with FNA and CNB", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "source": "University of Utah", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Utah", 
                "agency_class": "Other"
            }
        }, 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}